455 related articles for article (PubMed ID: 10878819)
21. Genetics of Parkinson's disease.
Gasser T
J Neurol; 2001 Oct; 248(10):833-40. PubMed ID: 11697518
[TBL] [Abstract][Full Text] [Related]
22. Parkin and alpha-synuclein: opponent actions in the pathogenesis of Parkinson's disease.
Baptista MJ; Cookson MR; Miller DW
Neuroscientist; 2004 Feb; 10(1):63-72. PubMed ID: 14987449
[TBL] [Abstract][Full Text] [Related]
23. Fibrillization of alpha-synuclein and tau in familial Parkinson's disease caused by the A53T alpha-synuclein mutation.
Kotzbauer PT; Giasson BI; Kravitz AV; Golbe LI; Mark MH; Trojanowski JQ; Lee VM
Exp Neurol; 2004 Jun; 187(2):279-88. PubMed ID: 15144854
[TBL] [Abstract][Full Text] [Related]
24. [A 73-year-old woman with familial Parkinson's disease].
Takanashi M; Urabe T; Ohta S; Hamano Y; Mori H; Shirai T; Kondo T; Mizuno Y
No To Shinkei; 1999 Dec; 51(12):1087-96. PubMed ID: 10654309
[TBL] [Abstract][Full Text] [Related]
25. alpha-Synuclein and parkin: coming together of pieces in puzzle of Parkinson's disease.
Burke RE
Lancet; 2001 Nov; 358(9293):1567-8. PubMed ID: 11716878
[No Abstract] [Full Text] [Related]
26. Pathogenesis of Parkinson's disease: dopamine, vesicles and alpha-synuclein.
Lotharius J; Brundin P
Nat Rev Neurosci; 2002 Dec; 3(12):932-42. PubMed ID: 12461550
[No Abstract] [Full Text] [Related]
27. A Drosophila model of Parkinson's disease.
Feany MB; Bender WW
Nature; 2000 Mar; 404(6776):394-8. PubMed ID: 10746727
[TBL] [Abstract][Full Text] [Related]
28. Parkinson's disease: one biochemical pathway to fit all genes?
Krüger R; Eberhardt O; Riess O; Schulz JB
Trends Mol Med; 2002 May; 8(5):236-40. PubMed ID: 12067634
[TBL] [Abstract][Full Text] [Related]
29. Human alpha-synuclein-harboring familial Parkinson's disease-linked Ala-53 --> Thr mutation causes neurodegenerative disease with alpha-synuclein aggregation in transgenic mice.
Lee MK; Stirling W; Xu Y; Xu X; Qui D; Mandir AS; Dawson TM; Copeland NG; Jenkins NA; Price DL
Proc Natl Acad Sci U S A; 2002 Jun; 99(13):8968-73. PubMed ID: 12084935
[TBL] [Abstract][Full Text] [Related]
30. Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy.
Conway KA; Lee SJ; Rochet JC; Ding TT; Williamson RE; Lansbury PT
Proc Natl Acad Sci U S A; 2000 Jan; 97(2):571-6. PubMed ID: 10639120
[TBL] [Abstract][Full Text] [Related]
31. Genetic testing in Parkinson's disease.
McInerney-Leo A; Hadley DW; Gwinn-Hardy K; Hardy J
Mov Disord; 2005 Jan; 20(1):1-10. PubMed ID: 15503301
[TBL] [Abstract][Full Text] [Related]
32. [Genetics and environmental factors of Parkinson disease].
Broussolle E; Thobois S
Rev Neurol (Paris); 2002 Dec; 158 Spec no 1():S11-23. PubMed ID: 12690660
[TBL] [Abstract][Full Text] [Related]
33. Overexpression of alpha-synuclein in rat substantia nigra results in loss of dopaminergic neurons, phosphorylation of alpha-synuclein and activation of caspase-9: resemblance to pathogenetic changes in Parkinson's disease.
Yamada M; Iwatsubo T; Mizuno Y; Mochizuki H
J Neurochem; 2004 Oct; 91(2):451-61. PubMed ID: 15447678
[TBL] [Abstract][Full Text] [Related]
34. [Genetics of Parkinson disease].
Brassat D; Durr A; Agid Y; Brice A
Rev Med Interne; 1999 Aug; 20(8):709-14. PubMed ID: 10480176
[TBL] [Abstract][Full Text] [Related]
35. Genetics of Parkinson's disease.
Mizuno Y; Hattori N; Mori H
Biomed Pharmacother; 1999 Apr; 53(3):109-16. PubMed ID: 10349506
[TBL] [Abstract][Full Text] [Related]
36. Gene dosage and pathogenesis of Parkinson's disease.
Eriksen JL; Przedborski S; Petrucelli L
Trends Mol Med; 2005 Mar; 11(3):91-6. PubMed ID: 15760766
[TBL] [Abstract][Full Text] [Related]
37. Linkage exclusion in French families with probable Parkinson' s disease.
Farrer M; Destée T; Becquet E; Wavrant-De Vrièze F; Mouroux V; Richard F; Defebvre L; Lincoln S; Hardy J; Amouyel P; Chartier-Harlin MC
Mov Disord; 2000 Nov; 15(6):1075-83. PubMed ID: 11104189
[TBL] [Abstract][Full Text] [Related]
38. Involvement of alpha-synuclein in Parkinson's disease and other neurodegenerative disorders.
Krüger R; Müller T; Riess O
J Neural Transm (Vienna); 2000; 107(1):31-40. PubMed ID: 10809401
[TBL] [Abstract][Full Text] [Related]
39. [Dopaminergic neuronal death in Parkinson's disease: is accumulation of unfolded proteins a cause or effect?].
Imai Y; Takahashi R
Tanpakushitsu Kakusan Koso; 2004 May; 49(7 Suppl):1113-7. PubMed ID: 15168542
[No Abstract] [Full Text] [Related]
40. Therapeutic strategies for Parkinson's disease based on data derived from genetic research.
Riess O; Berg D; Krüger R; Schulz JB
J Neurol; 2003 Feb; 250 Suppl 1():I3-10. PubMed ID: 12761628
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
